Figure 3.
Clinical response to NS7CAR T cells and postinfusion allo-HSCT. The clinical responses of patient BM and EMD after NS7CAR T infusion and transplantation after infusion are shown by swimmer plots. For the 9 patients (Pt.01, Pt.03, Pt.09, Pt.10, Pt. 11, Pt.12, Pt.13, Pt.15, and Pt.19) with EMD, the EMD response statuses are shown in separate bars and different colors from the BM response. Patients who had been followed up to the cutoff date and were no longer followed due to death or withdrawal are indicated. After transplant, Pt.09 did not have an EMD evaluation until 92 days after allo-HSCT, which was proven to be EMD CR. NR, no response. *Red asterisk indicates patients who relapsed from previous transplantation before NS7CAR T-cell infusion.

Clinical response to NS7CAR T cells and postinfusion allo-HSCT. The clinical responses of patient BM and EMD after NS7CAR T infusion and transplantation after infusion are shown by swimmer plots. For the 9 patients (Pt.01, Pt.03, Pt.09, Pt.10, Pt. 11, Pt.12, Pt.13, Pt.15, and Pt.19) with EMD, the EMD response statuses are shown in separate bars and different colors from the BM response. Patients who had been followed up to the cutoff date and were no longer followed due to death or withdrawal are indicated. After transplant, Pt.09 did not have an EMD evaluation until 92 days after allo-HSCT, which was proven to be EMD CR. NR, no response. *Red asterisk indicates patients who relapsed from previous transplantation before NS7CAR T-cell infusion.

Close Modal

or Create an Account

Close Modal
Close Modal